ZIM Laboratories Limited (BOM:541400)
138.45
-2.20 (-1.56%)
At close: Sep 25, 2026
ZIM Laboratories Employees
ZIM Laboratories had 632 employees as of March 31, 2026. The number of employees increased by 55 or 9.53% compared to the previous year.
Employees
632
Change (1Y)
55
Growth (1Y)
9.53%
Revenue / Employee
6.28M INR
Profits / Employee
58.48K INR
Market Cap
7.41B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 632 | 55 | 9.53% |
| Mar 31, 2025 | 577 | 21 | 3.78% |
| Mar 31, 2024 | 556 | 31 | 5.90% |
| Mar 31, 2023 | 525 | 20 | 3.96% |
| Mar 31, 2022 | 505 | 18 | 3.70% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Albert David | 1,476 |
| Lincoln Pharmaceuticals | 1,352 |
| Wanbury | 1,200 |
| Jenburkt Pharmaceuticals | 801 |
| Fermenta Biotech | 630 |
| Medicamen Biotech | 405 |
| Bharat Parenterals | 404 |
| Anuh Pharma | 323 |
ZIM Laboratories News
- 9 months ago - Why ZIM Laboratories has received CDSCO approval for its new Naproxen + Esomeprazole capsules - Business Upturn
- 1 year ago - ZIM Laboratories secures marketing authorization in Australia for urology drug combination - Business Upturn
- 1 year ago - ZIM Laboratories shares in focus as company gets first marketing approval in Australia - Business Upturn